ALPHALOGIX
Live / Registered — Registered (as of 13 Jul 2021)
What this means for you
Registered since 13 Jul 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 13 Jul 2027, and its filing window is open now).
Record
- Serial number
- 88679702
- Registration number
- 6420782
- Mark type
- Word mark
- Filed
- 04 Nov 2019
- Published for opposition
- 17 Mar 2020
- Registered
- 13 Jul 2021
- Next maintenance filing
- §8 declaration of use, due by 13 Jul 2027 (grace period to 13 Jan 2028)
- Attorney of record
- Quan Nguyen
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic products, namely, liquid therapeutic preparations derived from amnion and amniotic fluid for internal tissue implantation and for topical treatment to promote healing and rejuvenation of wounds bodily tissue
Owner
- ALPHALOGIX LLC, Phoenix, AZ, US
- ALPHALOGIX LLC, Phoenix, AZ, US
- ALPHALOGIX LLC, Phoenix, AZ, US
Prosecution history
- 13 Jul 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 13 Jul 2021 — REGISTERED-PRINCIPAL REGISTER
- 11 Jun 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Jun 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 May 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 12 May 2021 — USE AMENDMENT FILED
- 21 May 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 May 2021 — TEAS STATEMENT OF USE RECEIVED
- 24 Sept 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Sept 2020 — SOU EXTENSION 1 GRANTED
- 22 Sept 2020 — SOU EXTENSION 1 FILED
- 22 Sept 2020 — SOU TEAS EXTENSION RECEIVED
- 12 May 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Mar 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Mar 2020 — PUBLISHED FOR OPPOSITION